Xenon Pharmaceuticals Inc. · 5 hours ago
Director/Senior Director, Investor Relations
Xenon Pharmaceuticals Inc. is a neuroscience-focused biopharmaceutical company dedicated to drug discovery and clinical development. They are seeking a Director/Senior Director of Investor Relations to develop and execute the investor relations strategy and manage relationships with investors and analysts, effectively communicating the company's progress to the investment community.
BiopharmaBiotechnologyGeneticsHealth CareMedicalPharmaceutical
Responsibilities
Work with CEO and CFO to develop annual and longer-term strategic investor relations plans to communicate the company’s strategies and progress to the investment community
Manage the company’s participation in banking conferences, non-deal roadshows, and analyst/investor days through effective project management and relationship management strategies
Collaborate with the CFO, CEO, corporate affairs and senior executive team to craft clear, consistent messaging around company strategy, pipeline, and milestones
Partner with corporate affairs and legal teams to ensure all external communications are accurate and consistent with corporate messaging including presentation decks, news releases, and all other content
Drive and support preparation of earnings calls, press releases, and SEC filings (10-K, 10-Q, 8-K) in coordination with Finance and Legal
Lead development of briefing materials for management in preparation for investor meetings
Support the CEO and CFO in providing timely, consistent, compliant, and accurate responses; maintain database of interactions; and convey sentiments and feedback to management
Track and analyze insights on market dynamics, shareholder composition, and competitive positioning. analyst models, reports, and stock performance
Work closely with CEO and CFO to establish the optimal mix of shareholders through targeting initiatives
Work with Competitive Intelligence leader and other leaders across the company to monitor competitors’ performance -- along with industry, regulatory, and other relevant trends - to inform differentiated corporate messaging
Support the development and execution of the company’s financing strategy
Collaborate on execution of the annual meeting of shareholders together with the Legal, Finance, and Corporate Affairs teams
Develop and propose short- and long-term goals for the Investor Relations function in accordance with overall Company strategies
Plan and manage budget proposals and approved budgets in accordance with the Company’s strategic and operating plans and Finance policies
Act in accordance with Company policies, including, for example, the Code of Business Conduct and Ethics and ensure policies are understood and followed by direct reports, if any
Travel will be required
Other duties as assigned
Qualification
Required
Bachelor's degree or equivalent, ideally with a specialization in Finance, Business, Life Sciences, or Communications
Biotech or pharma industry experience is required; 8+ years of investor relations experience, ideally in the healthcare sector
Proven track record of developing positive long-term relations with analysts and the investor community
Deep understanding of capital markets and the financial statements and valuation models used by investors and analysts
Experience developing executive level communications and engaging directly with senior management
Superior interpersonal and relationship management skills
Excellent oral and written communication skills
Knowledge of Regulation FD and SEC reporting requirements impacting investor and other external communications
Outstanding organizational skills and attention to detail
Highly collaborative working style across internal and external teams
Preferred
Master's or advanced degree preferred
Benefits
Medical
Dental
Vision
Short-& long-term disability
Accidental death & dismemberment
Life insurance programs
Employee Assistance Program
Travel insurance
Retirement savings programs with company matching contributions
Vacation
Personal days
Sick days
End-of-year company shutdown
Training, Learning & Development program
Tuition Assistance program for advanced degrees
Company
Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need.
Funding
Current Stage
Public CompanyTotal Funding
$1.29BKey Investors
Neurocrine Biosciences
2023-11-29Post Ipo Equity· $300M
2022-06-22Post Ipo Equity· $287.5M
2021-10-05Post Ipo Equity· $345M
Recent News
2026-01-13
2025-12-05
2025-11-25
Company data provided by crunchbase